ClinicalTrials.Veeva

Menu

Occupational Therapy Programme of Patients With Dementia Performing Activities of Daily Living (OTSALD)

U

University of Extremadura

Status

Completed

Conditions

Dementia

Treatments

Other: Conventional ADLOccupational Therapy
Other: Stimulation of Activities Daily Living

Study type

Interventional

Funder types

Other

Identifiers

NCT02199353
46/2012

Details and patient eligibility

About

To assess the effectiveness of the Stimulation of Activities of Daily Living (SADL) Occupational Therapy programme on the independence of ADL by persons with dementia who are institutionalized. This programme is based on the recovery of the cognitive functions.

Full description

This study is a longitudinal and prospective clinical trial approved by the bioethics Commission of the University of Extremadura. 58 senior citizens institutionalized with dementia in residential homes in Extremadura (Spain) received a treatment focusing on activities of daily living with the SADL programme and with conventional occupational therapy during 5 weeks. The studied variables were the cognitive level and the independence level performing ADL. The variables were measured by an occupational therapist independent to the study at baseline, after 5 weeks of experimental treatment and 6 weeks after the treatment was completed. The standardized tests used were Barthel Index, Lobo's Cognoscitive mini test, Lawton and Brody Scale and Global Deterioration Scale (GDS).

Enrollment

58 patients

Sex

All

Ages

60+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Institutionalization in residential homes at least 6 months before the commencement of the study.
  • Diagnosis of dementia for at least one year according to the Diagnostic and Statistical Manual of Mental Disorders (DMS IV) criteria.
  • Over 60 years old.
  • Barthel Index scores greater than or equal to 40%.
  • Lobo´s Cognitive Mini Test scores greater than or equal to 15 points.
  • To be included in the BADL intervention programme of Occupational therapy in the previous 6 months and to have the informed consent signed by the legal tutor.

Exclusion criteria

  • To present psychological or behavior symptoms diagnosed by a doctor.
  • Barthel Index scores less than 40%
  • Not being included in the BADL intervention programme of Occupational therapy in the previous 6 months.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

58 participants in 2 patient groups

Stimulation of Activities Daily Living
Experimental group
Description:
The experimental group received the Stimulation of Activities of Daily Living (SADL) programme which is a new treatment approach created by the authors of this study for the training of activities of daily living (ADL) through cognitive intervention. The programme is based on the reestablishment of the cognitive functions implied in the performance of basic activities of daily living. The sequence of the sessions was always the same, varying the activities, subject, cognitive functions and BADL to work on. Each session started with an activity of temporal and space orientation, continued with the performance of the specific activity of the session and finished with a reminiscence activity. The treatment was applied twice a week (Tuesday and Thursday) for 45 minutes during 5 weeks.
Treatment:
Other: Stimulation of Activities Daily Living
Conventional ADLoccupational therapy
Active Comparator group
Description:
The control group treatment was based on a conventional occupational therapy intervention for the management of ADL deficits. The compensation approach was used and environment modifications and simplification of activities were applied as the intervention method. The treatment was carried out twice a week (Tuesday and Thursday) for 45 minutes during 5 weeks.
Treatment:
Other: Conventional ADLOccupational Therapy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems